BIO-TECHNE Corp — Director's Dealing 2015

Aug 11, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2015-08-07

Reporting Person: Bazan J. Fernando (Chief Technical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-07	Stock Option (Right to Buy)	$108.49	A	10000	Acquired	2022-08-07	Common Stock (10000)	Direct
2015-08-07	Stock Options (Right to Buy)	$108.49	A	5000	Acquired	2022-08-07	Common Stock (5000)	Direct
2015-08-07	Restricted Stock Units	$	A	800	Acquired		Common Stock (800)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$76.02	2020-07-31	Common Stock (10000)	10000	Direct
Stock Option (Right to Buy)	$76.02	2020-07-31	Common Stock (15000)	15000	Direct
Stock Option (Right to Buy)	$94.35	2021-08-12	Common Stock (15000)	15000	Direct

Footnotes

F1: Vests 3,333 shares on each of 8/1/14 and 8/1/15 and 3,334 shares on 8/1/16.

F2: Vests 3,750 shares on each of 8/1/14, 8/1/15, 8/1/16 and 8/1/17.

F3: Vests 3,750 shares on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.

F4: Vests 2,500 shares on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.

F5: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F6: Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.